NFKB1 and breast carcinoma: Recent evidence from a breast cancer cell line and a human melanoma cell line suggests that Snap29 plays a role in the TNFα-NF-κB-FOXP3 signaling axis, and silencing Snap29 promotes tumor cell migration [21].